Literature DB >> 20558247

Serotypes 1, 7F and 19A became the leading causes of pediatric invasive pneumococcal infections in Portugal after 7 years of heptavalent conjugate vaccine use.

Sandra I Aguiar1, Maria J Brito, José Gonçalo-Marques, José Melo-Cristino, Mário Ramirez.   

Abstract

We characterized 353 isolates responsible for pediatric invasive pneumococcal infections (IPD) in Portugal between 2006 and 2008. Serotypes included in the seven-valent conjugate vaccine (PCV7) accounted for 17% of IPD. Serotypes 1, 7F and 19A were the most frequent causes of IPD and the later consolidated as the most frequent serotype among erythromycin and penicillin non-susceptible isolates. Serotype 1 was associated with older children and empyemas, while serotype 19A was associated with IPD in younger (<2 years) children. The higher valency vaccines PCV10 and PCV13 have a potentially superior coverage, 55% and 83% respectively, but non-vaccine serotypes are emerging as important causes of IPD. A decline of resistance with patient age was noted. Comparing with previous data from Portugal, this study showed a continued decline of PCV7 serotypes and that overall resistance has stabilized following the initial decline of the first post-PCV7 years. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20558247     DOI: 10.1016/j.vaccine.2010.06.008

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  23 in total

1.  Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype.

Authors:  Raquel Sá-Leão; Francisco Pinto; Sandra Aguiar; Sónia Nunes; João A Carriço; Nelson Frazão; Natacha Gonçalves-Sousa; José Melo-Cristino; Hermínia de Lencastre; Mário Ramirez
Journal:  J Clin Microbiol       Date:  2011-01-26       Impact factor: 5.948

2.  Sequetyping: serotyping Streptococcus pneumoniae by a single PCR sequencing strategy.

Authors:  Marcus H Leung; Kevin Bryson; Kathrin Freystatter; Bruno Pichon; Giles Edwards; Bambos M Charalambous; Stephen H Gillespie
Journal:  J Clin Microbiol       Date:  2012-05-02       Impact factor: 5.948

3.  Pneumococcal serotypes causing pneumonia with pleural effusion in pediatric patients.

Authors:  Jigui Yu; Douglas Salamon; Mario Marcon; Moon H Nahm
Journal:  J Clin Microbiol       Date:  2010-12-01       Impact factor: 5.948

4.  Are risk factors associated with invasive pneumococcal disease according to different serotypes?

Authors:  Pilar Ciruela; Núria Soldevila; Laura Selva; Sergi Hernández; Juan Jose Garcia-Garcia; Fernando Moraga; Mariona F de Sevilla; Gemma Codina; Ana Maria Planes; Cristina Esteva; Francis Coll; Neus Cardeñosa; Iolanda Jordan; Joan Batalla; Luis Salleras; Carmen Muñoz-Almagro; Angela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

5.  Serotypes and genotypes of invasive Streptococcus pneumoniae before and after PCV10 implementation in southern Brazil.

Authors:  Juliana Caierão; Paulina Hawkins; Fernando Hayashi Sant'anna; Gabriela Rosa da Cunha; Pedro Alves d'Azevedo; Lesley McGee; Cícero Dias
Journal:  PLoS One       Date:  2014-10-30       Impact factor: 3.240

6.  Evidence of a clonal expansion of Streptococcus pneumoniae serotype 19A in adults as in children assessed by the DiversiLab® system.

Authors:  O Hurmic; N Grall; M Al Nakib; C Poyart; S Grondin; M-C Ploy; E Varon; J Raymond
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-15       Impact factor: 3.267

7.  Epidemiology of vaccine-preventable invasive diseases in Catalonia in the era of conjugate vaccines.

Authors:  Pilar Ciruela; Ana Martínez; Conchita Izquierdo; Sergi Hernández; Sonia Broner; Carmen Muñoz-Almagro; Àngela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2013-01-09       Impact factor: 3.452

8.  Macrolide resistance determinants among Streptococcus pneumoniae isolates from carriers in Central Greece.

Authors:  Ioanna N Grivea; Alexia Sourla; Eleni Ntokou; Denise C Chryssanthopoulou; Alexandra G Tsantouli; George A Syrogiannopoulos
Journal:  BMC Infect Dis       Date:  2012-10-11       Impact factor: 3.090

9.  Epidemiology and population structure of serotypes 1, 5 and 7f carried by children in Portugal from 1996-2010 before introduction of the 10-valent and 13-valent pneumococcal conjugate vaccines.

Authors:  Sónia T Almeida; Hermínia de Lencastre; Raquel Sá-Leão
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

Review 10.  Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.

Authors:  Catherine Weil-Olivier; Mark van der Linden; Iris de Schutter; Ron Dagan; Lorenzo Mantovani
Journal:  BMC Infect Dis       Date:  2012-09-07       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.